breast cancer cell line (MCF-7) and normal breast cell line (MCF-10A) was purchased from KeyGEN biotechnology Company (Nanjing, China).
Instruments.
High resolution transmission electron microscopy (HRTEM) was taken on a JEM-2100 electron microscope. Fluorescence spectra were acquired from Edinburgh Fluorescence Spectrometer with a Xenon lamp. Absorption spectra were carried out on a pharmaspec UV-1700 UV-visible spectrophotometer (Shimadzu, Japan). Absorbance was measured in a microplate reader (Synergy 2, Biotek, USA) in the MTT assay. Success of each reaction step was confirmed by monitoring the changes in zeta potential with a Malvern Zeta Sizer Nano (Malvern Instruments). A TCS SP5 confocal laser scanning microscopy (Leica Co., Ltd. Germany) was used for performing the confocal fluorescence imaging. 
Synthesis of

Synthesis of DNA linking of upconversion nanoparticles (UCNPs@PAA-DNA).
The PAA-capped UCNPs were covalently encapsulated with DNA as reported previously. Briefly, 0.5 mg of PAA@UCNPs in 1 mL MES buffer (10 mM, pH 6.0)
were activated by EDC and NHS (680 nM) to form the active succinimidyl ester for 30 min. Then the DNA that was dissolves in water was added to the mixture. After 24 h magnetic stirring in dark, the UCNPs@PAA-DNA was purified by centrifugation (14000 rpm for 10 min) and washed with water to remove excess reactant.
In vitro detection of 1 O2. UCNPs@PAA-DNA1/2 (100 μg/mL) was dispersed in PBS buffer with different pH (6.5 or 7.4) containing a special probe 9,10-anthracenediylbis(methylene)dimalonic acid (ABMD, 0.1 mM). Then the solution was conducted with laser irradiation (1.5 W·cm -2 , 5 min) or not. The solution was then centrifuged and the supernatant was measured to obtain UV-vis spectra.
Cell culture. MCF-7 and MCF-10a cells were cultured in Dulbecco's modified
Eagles medium (DMEM) with 10% fetal bovine serum and 100 U/ml 1% antibiotics penicillin/streptomycin and maintained at 37 °C in a 100% humidified atmosphere containing 5% CO2. In vivo antitumor efficacy via intravenous injection. When the tumor volume reached to approximately 150 mm 3 the tumor-bearing mice were divided into four groups. The treatments were respectively PBS only, laser only, UCNPs@PAA-DNA1/3 combined with laser irradiation and UCNPs@PAA-DNA1/2 combined with laser irradiation. 100 μL PBS, 100 μL 1.0 mg/mL UCNPs@PAA-DNA1/3 or UCNPs@PAA-DNA1/2 in PBS were intravenously injected into the mice via tail vein.
In vitro
After 8 h, laser treatment was performed on the tumor region with 980 nm laser at a power of 1.5 W•cm -2 for 5min. The tumor size and the body weights of the mice were observed every other day for 14 days (day 0, 2, 4, 6, 8, 10, 12 and 14). Table S1 . DNA sequences used in this work. 2.1nmol 1.9nmol
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